| 1 |
Moayyedi P, Talley NJ.Gastro-oesophageal reflux disease[J]．Lancet，2006，367(9528):2086-2100.
|
| 2 |
Wong BC, Kinoshita Y．Systematic review on epidemiology of gastroesophageal reflux disease in Asia[J]．Clin Gastroenterol Hepatol，2006，4(4):398-407.
|
| 3 |
Cicala M, Emerenziani S, Guarino MP，et al.Proton pump inhibitor resistance，the real challenge in gastro-esophageal reflux disease[J]．World J Gastroenterol，2013，19(39):6529-6535.
|
| 4 |
Li YN, Zhao XN, Li TT，et al.Clinical characteristics of elderly patients with refractory gastroesophageal reflux disease[J]．Int J Gerontol，2016，10(2):100-104.
|
| 5 |
Fass R, Shapiro MR, Dekel R，et al.Systematic review：proton‐pump inhibitor failure in gastro-oesophageal reflux disease-where next？[J]．Aliment pharmacol Ther，2005，22(2):79-94.
|
| 6 |
Moraes-Filho JP, Navarro-Rodriguez T, Eisig JN，et al.Comorbidities are frequent in patients with gastroesophageal reflux disease in a tertiary health care hospital[J]．Clinics，2009，64(8):785-790.
|
| 7 |
Tutuian R．Adverse effects of drugs on the esophagus[J]．Best Pract Res Clin Gastroenterol，2010，24(2):91-97.
|
| 8 |
Abid S, Mumtaz K, Jafri W，et al.Pill-induced esophageal injury：endoscopic features and clinical outcomes[J]．Endoscopy，2005，37(8):740-744.
|
| 9 |
van der Velden AW, de Wit NJ, Quartero AO，et al.Maintenance treatment for GERD：residual symptoms are associated with psychological distress[J]．Digestion，2008，77(3-4):207-213.
|
| 10 |
El-Serag HB, Ergun GA, Pandolfino J，et al.Obesity increases oesophageal acid exposure [J]．Gut，2007，56(6):749-755.
|
| 11 |
Ayazi S, Hagen JA, Chan LS，et al.Obesity and gastroesophageal reflux：quantifying the association between body mass index，esophageal acid exposure，and lower esophageal sphincter status in a large series of patients with reflux symptoms[J]．J Gastrointest Surg，2009，13(8):1440-1447.
|
| 12 |
Crowell MD, Bradley A, Hansel S，et al.Obesity is associated with increased 48-h esophageal acid exposure in patients with symptomatic gastroesophageal reflux[J]．Am J Gastroenterol，2009，104(3):553-559.
|
| 13 |
Blouin RA, Warren GW.Pharmacokinetic considerations in obesity[J]．J Pharm Sci，1999，88(1):1-7.
|
| 14 |
Jacobson BC.Body mass index and the efficacy of acid-mediating agents for GERD[J/OL]．Dig Dis Sci，2008，53(9):2313-2317.
|
| 15 |
Barak N, Ehrenpreis ED, Harrison JR，et al.Gastro-oesophageal reflux disease in obesity：pathophysiological and therapeutic considerations[J]．Obes Rev，2002，3(1):9-15.
|
| 16 |
Galmiche JP, Clouse RE, Bálint A，et al.Functional esophageal disorders[J]．Gastroenterol，2006，130(5):1459-1465.
|
| 17 |
Dunbar KB, Agoston AT, Odze RD，et al.Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes[J]．JAMA，2016，315(19):2104-2112.
|
| 18 |
Richter JE.How to manage refractory GERD[J]．Nat Clin Pract Gastroenterol Hepatol，2007，4(12):658-664.
|
| 19 |
Straumann A, Conus S, Degen L，et al.Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis[J]．Gastroenterology，2010，139(5):1526-1537.
|
| 20 |
Mainie I, Tutuian R, Shay S，et al.Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy：a multicentre study using combined ambulatory impedance-pH monitoring[J]．Gut，2006，55(10):1398-1402.
|
| 21 |
Peghini PL, Katz PO, Bracy NA，et al.Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors[J]．Am J Gastroenterol，1998，93(5):763-767.
|
| 22 |
Hershcovici T, Jha LK, Cui H，et al.Night-time intra-oesophageal bile and acid：a comparison between gastro-oesophageal reflux disease patients who failed and those who were treated successfully with a proton pump inhibitor[J]．Aliment Pharm Ther，2011，33(7):837-844.
|
| 23 |
Izawa S, Funaki Y, Iida A，et al.The role of gastroesophageal reflux in relation to symptom onset in patients with proton pump inhibitor-refractory nonerosive reflux disease accompanied by an underlying esophageal motor disorder[J]．Digestion，2014，89(1):61-67.
|
| 24 |
Pehlivanov N, Liu J, Mittal RK.Sustained esophageal contraction：a motor correlate of heartburn symptom[J]．Am J Physiol Gastrointest Liver Physio，2001，281(3):G743-G751.
|
| 25 |
Calabrese C, Fabbri A, Bortolotti M，et al.Dilated intercellular spaces as a marker of oesophageal damage：comparative results in gastro-oesophageal reflux disease with or without bile reflux[J]．Aliment Pharmacol Ther，2003，18(5):525-532.
|
| 26 |
Tobey NA, Hosseini SS, Caymaz-Bor C，et al.The role of pepsin in acid injury to esophageal epithelium[J]．Am J Gastroenterol，2001，96(11):3062-3070.
|
| 27 |
Ichikawa H, Sugimoto M, Sugimoto K，et al.Rapid metabolizer genotype of CYP2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis[J]．J Gastroenterol Hepatol，2016，31(4):716-726.
|
| 28 |
Moraes-Filho JP.Refractory gastroesophageal reflux disease[J]．Arq Gastroenterol，2012，49(4):296-301.
|
| 29 |
Tutuian R, Vela MF, Shay S \S，et al.Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring[J]．J Clin Gastroenterol，2003，37(3):206-215.
|
| 30 |
de Bortoli N, Martinucci I, Savarino E，et al.Association between baseline impedance values and response proton pump inhibitors in patients with heartburn[J]．Clin Gastroenterol Hepatol，2015，13(6):1082-1088.
|
| 31 |
Zhong C, Duan L, Wang K，et al.Esophageal intraluminal baseline impedance is associated with severity of acid reflux and epithelial structural abnormalities in patients with gastroesophageal reflux disease[J]．J Gastroenterol，2013，48(5):601-610.
|
| 32 |
Kessing BF, Bredenoord AJ, Weijenborg PW，et al.Esophageal acid exposure decreases intraluminal baseline impedance levels[J]．Am J Gastroenterol，2011，106(12):2093-2097.
|
| 33 |
Farré R, Blondeau K, Clement D，et al.Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique[J]．Gut，2011，60(7):885-892.
|
| 34 |
Ciriza－de－Los－Rios C, Canga－Rodríguez－Valcárcel F．High－resolution manometry and impedance－pH/manometry：Novel techniques for the advancement of knowledge on esophageal function and their clinical role[J]．Rev Esp Enferm Dig，2009，101(12):861-869.
|
| 35 |
Vieth M, Mastracci L, Vakil N，et al.Epithelial thickness is a marker of gastroesophageal reflux disease[J]．Clin Gastroenterol Hepatol，2016，14(11):1544-1551.
|
| 36 |
Straumann A, Conus S, Degen L，et al.Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis[J]．Gastroenterology，2010，139(5):1526-1537.
|
| 37 |
Leiman DA, Riff BP, Morgan S，et al.Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms：a systematic review and meta－analysis[J]．Dis Esophagus，2017，30(2):1-8.
|
| 38 |
Stefanidis D, Hope WW, Kohn GP，et al.Guidelines for surgical treatment of gastroesophageal reflux disease[J]．Surg Endosc，2010，24(11):2647-2669.
|
| 39 |
Kahrilas PJ, Shaheen NJ, Vaezi MF，et al.American gastroenterological association medical position statement on the management of gastroesophageal reflux disease[J]．Gastroenterology，2008，135(4):1383-1391.
|
| 40 |
Funk LM, Kanji A, Scott Melvin W，et al.Elective antireflux surgery in the US：an analysis of national trends in utilization and inpatient outcomes from 2005 to 2010[J]．Surg Endosc，2014，28(5):1712-1719.
|
| 41 |
Noar M, Squires P, Noar E，et al.Long－term maintenance effect of radiofrequency energy delivery for refractory GERD：a decade later[J]．Surg Endosc，2014，28(8):2323-2333.
|
| 42 |
Dickman R, Schiff E, Holland A，et al.Clinical trial：acupuncture vs.doubling the proton pump inhibitor dose in refractory heartburn[J]．Aliment Pharmacol Ther，2007，26(10):1333-1344.
|
| 43 |
Zhang X, Jin HF, Fan YH，et al.Effects and mechanisms of transcutaneous electroacupuncture on chemotherapy－induced nausea and vomiting[J]．EvidBased Complement Alternat Med，2014;2014:860631
|
| 44 |
Ji T, Li X, Lin L，et al.An alternative to current therapies of functional dyspepsia：self－administrated transcutaneous electroacupuncture improves dyspeptic symptoms[J]．Evid Based Complement Alternat Med，2014.
|
| 45 |
Zhang N, Song G, Chen J，et al.Ameliorating effects and autonomic mechanisms of needle-less transcutaneous electrical stimulation at ST36 on stress-induced impairment in gastric slow waves[J]．J Gastroenterol Hepatol，2015，30(11):1574-1581.
|
| 46 |
Huang Z, Zhang N, Xu F，et al.Ameliorating effect of transcutaneous electroacupuncture on impaired gastric accommodation induced by cold meal in healthy subjects[J]．J Gastroenterol Hepatol，2016，31(3):561-566.
|
| 47 |
Rodríguez L, Rodriguez P, Neto MG，et al.Short-term electrical stimulation of the lower esophageal sphincter increases sphincter pressure in patients with gastroesophageal reflux disease[J]．Neurogastroenterol Motil，2012，24(5):446-450.
|
| 48 |
Soffer E, Rodríguez L, Rodriguez P，et al.Effect of electrical stimulation of the lower esophageal sphincter in gastroesophageal reflux disease patients refractory to proton pump inhibitors[J]．World J Gastrointest Pharmacol Ther，2016，7(1):145-155.
|
| 49 |
Jain D, Singhal S．Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease：Where Do We Stand？[J/OL]．Clin Endosc，2016，49(2):147-156.
|
| 50 |
Nojkov B, Rubenstein JH, Adlis SA，et al.The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease[J]．Aliment Pharmacol Ther，2008，27(6):473-482.
|